JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

JNJ

168.03

+1.28%↑

NVS

117.07

+0.85%↑

ABT

127.93

+1.35%↑

MDT

92.47

+0.6%↑

ELV.US

288.56

+1%↑

Search

Harmony Biosciences Holdings Inc

Chiusa

SettoreSettore sanitario

35.31 -1.34

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

35.29

Massimo

36.16

Metriche Chiave

By Trading Economics

Entrata

-3.9M

46M

Vendite

-17M

185M

P/E

Media del settore

13.649

38.156

Margine di Profitto

24.663

Dipendenti

268

EBITDA

-10M

56M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+38.09% upside

Dividendi

By Dow Jones

Utili prossimi

5 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

314M

2.1B

Apertura precedente

36.65

Chiusura precedente

35.31

Notizie sul Sentiment di mercato

By Acuity

50%

50%

157 / 375 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

Harmony Biosciences Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

29 lug 2025, 23:57 UTC

Acquisizioni, Fusioni, Takeovers

EQT: To Spend Y407.82B for Tender Offer

29 lug 2025, 23:56 UTC

Acquisizioni, Fusioni, Takeovers

EQT: Tender Offer Price Is Y5,700 a Share

29 lug 2025, 23:54 UTC

Acquisizioni, Fusioni, Takeovers

EQT To Start Tender Offer for Fujitec

29 lug 2025, 23:50 UTC

Discorsi di Mercato

Nikkei May Fall Amid Uncertainty Over Earnings, Domestic Politics -- Market Talk

29 lug 2025, 23:36 UTC

Discorsi di Mercato

Gold Steady Ahead of FOMC Decision -- Market Talk

29 lug 2025, 22:57 UTC

Discorsi di Mercato

Perseus May Step Up Capital Management at FY 2025 Result -- Market Talk

29 lug 2025, 22:50 UTC

Discorsi di Mercato

Mondelez Warns of Price Increases in North America -- Market Talk

29 lug 2025, 22:44 UTC

Acquisizioni, Fusioni, Takeovers

St Barbara: Potential Divestment of Nova Scotia Ops to be Weighed in 1Q FY26

29 lug 2025, 22:41 UTC

Acquisizioni, Fusioni, Takeovers

St Barbara FY25 All-in Sustaining Cost A$4,582/Oz

29 lug 2025, 22:41 UTC

Acquisizioni, Fusioni, Takeovers

St Barbara 4Q All-in Sustaining Cost A$4,613/Oz

29 lug 2025, 22:35 UTC

Utili

IGO Maintains Nova Life of Mine Production Guidance

29 lug 2025, 22:35 UTC

Utili

IGO Expects FY 2026 Greenbushes Output of 1.50 Million-1.65 Million Tons

29 lug 2025, 22:35 UTC

Utili

IGO Expects FY 2026 Greenbushes Cash Costs of A$310-A$360/Ton

29 lug 2025, 22:34 UTC

Utili

IGO Expects Train 1 of Kwinana Refinery to Be Fully Impaired

29 lug 2025, 22:34 UTC

Utili

IGO Expects to Impair Kwinana Refinery Assets by A$70 Million-A$90 Million

29 lug 2025, 22:34 UTC

Discorsi di Mercato
Utili

Mondelez Snack Demand Holding Up Better in Europe Than U.S. -- Market Talk

29 lug 2025, 22:33 UTC

Utili

IGO Had A$279.7 Million of Cash at End-June

29 lug 2025, 22:33 UTC

Utili

IGO 4Q Underlying Free Cash A$2.4 Million

29 lug 2025, 22:33 UTC

Utili

IGO FY Sales Revenue A$512.5 Million

29 lug 2025, 22:33 UTC

Utili

IGO 4Q Sales Revenue A$126.9 Million, Up 15% on 3Q

29 lug 2025, 22:32 UTC

Utili

IGO FY Nickel Production 17,173 Tons

29 lug 2025, 22:32 UTC

Utili

IGO 4Q Nickel Production 5,107 Tons, Up 22% on 3Q

29 lug 2025, 22:32 UTC

Utili

IGO 4Q Lithium Hydroxide Production 2,126 Tons, Up 36% on 3Q

29 lug 2025, 22:31 UTC

Discorsi di Mercato
Utili

Global Equities Roundup: Market Talk

29 lug 2025, 22:31 UTC

Discorsi di Mercato
Utili

Mondelez Sees Consumers Trading Down, Buying in Bulk -- Market Talk

29 lug 2025, 22:31 UTC

Utili

IGO 4Q Spodumene Cash Cost A$366/Ton, Up 7% on 3Q

29 lug 2025, 22:31 UTC

Utili

IGO FY Spodumene Production 1.48 Million Tons

29 lug 2025, 22:30 UTC

Utili

IGO 4Q Spodumene Production 340,000 Tons, Flat on 3Q

29 lug 2025, 22:30 UTC

Utili

IGO 4Q Underlying Ebitda A$62 Million

29 lug 2025, 22:22 UTC

Utili

Starbucks Abandons Mobile Order, Pickup-Only Stores -- WSJ

Confronto tra pari

Modifica del prezzo

Harmony Biosciences Holdings Inc Previsione

Obiettivo di Prezzo

By TipRanks

38.09% in crescita

Previsioni per 12 mesi

Media 49.38 USD  38.09%

Alto 70 USD

Basso 31 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Harmony Biosciences Holdings Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

8 ratings

6

Acquista

1

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

29.8 / N/ASupporto e resistenza

A breve termine

Weak Bullish Evidence

A termine intermedio

Weak Bullish Evidence

A lungo termine

Very Strong Bearish Evidence

Sentiment

By Acuity

157 / 375 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.